CytoMed Therapeutics
GDTC
#9837
Rank
A$45.42 M
Marketcap
$3.94
Share price
-4.03%
Change (1 day)
26.50%
Change (1 year)

CytoMed Therapeutics (GDTC) - Cash on Hand

Cash on Hand as of December 2023 : A$11.26 Million

According to CytoMed Therapeutics's latest financial reports the company has A$11.26 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

CytoMed Therapeutics - Cash on Hand chart (from 2021 to 2023)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31A$9.99 M477.31%
2022-12-31A$1.73 M-32.46%
2021-12-31A$2.56 M194.6%
2020-12-31A$0.87 M